Advanced search
Publication Cover
Journal of Medical Economics Volume 13, 2010 - Issue 1
Submit an article Journal homepage
948
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The cost effectiveness and budget impact of natalizumab for formulary inclusion

Justin Bakhshai University of Maryland School of Pharmacy, Baltimore, MD USA
,
Raymond Bleu-Lainé University of Maryland School of Pharmacy, Baltimore, MD USA
,
Miah Jung University of Maryland School of Pharmacy, Baltimore, MD USA
,
Jeanne Lim University of Maryland School of Pharmacy, Baltimore, MD USA
,
Christian Reyes University of Maryland School of Pharmacy, Baltimore, MD USA
,
Linda Sun University of Maryland School of Pharmacy, Baltimore, MD USA
,
Charmaine Rochester University of Maryland School of Pharmacy, Baltimore, MD USA
&
Fadia T. Shaya University of Maryland School of Pharmacy, Baltimore, MD USACorrespondence[email protected]
 show all
Pages 63-69 | Published online: 22 Dec 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Surachat Ngorsuraches & Nabin Poudel. (2021) Incorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review. Expert Review of Pharmacoeconomics & Outcomes Research 21:2, pages 183-195.
Read now
Daniel Resende Faleiros, Juliana Álvares, Alessandra Maciel Almeida, Vânia Eloisa de Araújo, Eli Iola Gurgel Andrade, Brian B. Godman, Francisco A. Acurcio & Augusto A. Guerra Júnior. (2016) Budget impact analysis of medicines: updated systematic review and implications. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 257-266.
Read now
Machaon M Bonafede, Barbara H Johnson & Crystal Watson. (2014) Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US. ClinicoEconomics and Outcomes Research 6, pages 11-20.
Read now
Leonardo Koeser & Paul McCrone. (2013) Cost–effectiveness of natalizumab in multiple sclerosis: an updated systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 13:2, pages 171-182.
Read now

Articles from other publishers (12)

Tomas Mlcoch, Barbora Decker & Tomas Dolezal. (2021) Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease. Applied Health Economics and Health Policy 19:4, pages 593-604.
Crossref
Anna Mokrova, Susanna Sologova & Victoria Ignatyeva. (2020) Modelling expenses for multiple sclerosis treatment. Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology):3, pages 11-34.
Crossref
B Polistena, F Spandonaro, R Capra, S Fantaccini, L Santoni, GB Zimatore & C Gasperini. (2019) The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri ® PharmacoEconomics (TyPE) Study . Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2019, pages 228424031985295.
Crossref
Sergio Iannazzo, Ange-Christelle Iliza & Louise Perrault. (2017) Disease-Modifying Therapies for Multiple Sclerosis: A Systematic Literature Review of Cost-Effectiveness Studies. PharmacoEconomics 36:2, pages 189-204.
Crossref
Nadia Pillai, Mark Dusheiko, Bernard Burnand & Valérie Pittet. (2017) A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLOS ONE 12:10, pages e0185500.
Crossref
Josephine Mauskopf & Stephanie Earnshaw. (2016) A Methodological Review of US Budget-Impact Models for New Drugs. PharmacoEconomics 34:11, pages 1111-1131.
Crossref
Aurélien Lathuilière, Nicolas Mach & Bernard Schneider. (2015) Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System. International Journal of Molecular Sciences 16:12, pages 10578-10600.
Crossref
Shien Guo, Christopher Pelligra, Catherine Saint-Laurent Thibault, Luis Hernandez & Anuraag Kansal. (2014) Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches. PharmacoEconomics 32:6, pages 559-572.
Crossref
Derek H. Tang, Amanda R. Harrington, Jeannie K. Lee, Mark Lin & Edward P. Armstrong. (2013) A Systematic Review of Economic Studies on Biological Agents Used to Treat Crohn’s Disease. Inflammatory Bowel Diseases 19:12, pages 2673-2694.
Crossref
Yamei Yu, Thomas Schürpf & Timothy A. Springer. (2013) How Natalizumab Binds and Antagonizes α4 Integrins. Journal of Biological Chemistry 288:45, pages 32314-32325.
Crossref
Annie Hawton, James Shearer, Elizabeth Goodwin & Colin Green. (2013) Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis. Applied Health Economics and Health Policy 11:4, pages 331-341.
Crossref
David Yamamoto & Jonathan D. Campbell. (2012) Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature. Autoimmune Diseases 2012, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.